Meeting Archive:
Risky Women: Disrupting Simple Notions of Women's HIV Risk

Meeting Description:
In 2012, the FDA approved Truvada for PrEP use among adult women and men who are "at risk" of HIV infection in the U.S.  But exactly which women are at risk, how such risk is defined and understood, and whether or not women see themselves in this way is not entirely clear.  Speakers in this webinar will present what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.
Presentations will be followed by discussion and a question and answer period. The webinar is co-sponsored by AVAC, the HIV Prevention Justice Project, the National Women's Health Network,SisterLove, Inc. and the Well Project.
Date: Mon, Dec 9, 2013
Time: 11:00 AM EST
Duration: 1 hour 30 minutes
Host(s): AVAC, HIV PJA, NWHN, SisterLove and The Well Project